- Filed
- Feb 3, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jan 30, 2025 | 59.65M sh |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $49.42M |
| Short Term Investments | Q1 2025 · Sep 30, 2024 | $50.08M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $221.4M |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $226.32M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $69.65M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $71.01M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $152.64M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $141.63M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $345.31M |
| Current Assets | Q1 2025 · Sep 30, 2024 | $346.78M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $608.58M |
| Total Assets | Q1 2025 · Sep 30, 2024 | $614.32M |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 57.5M sh |
| Capex | Q1 2025 · Dec 31, 2023 | $1.51M |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | −$22.97M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $590.04M |
| Stockholders Equity | Q1 2025 · Sep 30, 2023 | $623.43M |
| Eps Diluted | Q1 2025 · Dec 31, 2023 | −$0.75 |
| Eps Basic | Q1 2025 · Dec 31, 2023 | −$0.75 |
| Sga Expense | Q1 2025 · Dec 31, 2023 | $52.84M |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $23.1M |
| Net Income | Q1 2025 · Dec 31, 2023 | −$43.01M |
| Operating Income | Q1 2025 · Dec 31, 2023 | −$46.98M |
| Cost Of Revenue | Q1 2025 · Dec 31, 2023 | $42.54M |
| Revenue | Q1 2025 · Dec 31, 2023 | $71.5M |